We are live on
!
Find out more
Arcutis Biotherapeutics
ARQT
ARQT
269 hedge funds and large institutions have $3.11B invested in Arcutis Biotherapeutics in 2026 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 104 increasing their positions, 87 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
337% more call options, than puts
Call options by funds: $9.97M | Put options by funds: $2.28M
20% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 87
1.17% more ownership
Funds ownership: 105.4% → 106.57% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
5% less funds holding
Funds holding: 282 → 269 (-13)
13% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 46
17% less capital invested
Capital invested by funds: $3.75B → $3.11B (-$632M)
Holders
269
Holders Change
-13
Holders Change %
-4.61%
% of All Funds
3.31%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
40
Increased
104
Reduced
87
Closed
46
Calls
$9.97M
Puts
$2.28M
Net Calls
+$7.69M
Net Calls Change
-$10.8M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$50.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$20.6M |
| 3 |
Squarepoint
New York
|
+$16.5M |
| 4 |
BAMCO Inc
New York
|
+$14.5M |
| 5 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$14.2M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$45.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.3M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$16.8M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13.8M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$12.3M |
